Marisol Perez-Toledo

Medicine & Life Sciences

1. SARS Virus 100%
2. Immunoglobulin G 52%
3. Antibody Formation 39%
4. Antibodies 34%
5. Immunoglobulin M 33%
6. Infections 33%
7. Glycoproteins 31%
8. Salmonella 30%
9. Follicular Dendritic Cells 27%
10. Salmonella Infections 27%
11. Typhoid-Paratyphoid Vaccines 26%
12. Antigens 25%
13. Conjugate Vaccines 23%
14. Germinal Center 22%
15. Complement Activation 22%
16. Infection Control 21%
17. Salmonella typhimurium 20%
18. Saliva 18%
19. Polysaccharides 18%
20. Immunoglobulin A 17%
21. Vaccines 15%
22. Seroepidemiologic Studies 15%
23. Thrombosis 14%
24. Vaccination 14%
25. Serum 13%
26. O Antigens 13%
27. Nucleocapsid 13%
28. Enzyme-Linked Immunosorbent Assay 12%
29. Nucleoproteins 12%
30. Health Personnel 11%
31. Serology 11%
32. Spleen 10%
33. Humoral Immunity 10%
34. Granuloma 9%
35. Polymerase Chain Reaction 9%
36. Lipopolysaccharides 9%
37. Complement C4b 8%
38. Chronic Renal Insufficiency 8%
39. Coronavirus nucleocapsid protein 8%
40. Viral Antibodies 8%
41. Complement C5b 8%
42. Membrane Proteins 8%
43. Bacteria 7%
44. Memory 7%
45. Animal Models 6%
46. Classical Complement Pathway 6%
47. Immunization 6%
48. Cross-Sectional Studies 6%
49. Pediatrics 6%
50. Complement System Proteins 6%